Moneycontrol
HomeNewsBusinessStocksGeneric medicines exempted from Trump’s 100% pharma tariffs, but uncertainty continues
Trending Topics

Generic medicines exempted from Trump’s 100% pharma tariffs, but uncertainty continues

While generic drugs are exempted from the latest action, companies still face uncertainty over tariffs due to an investigation by the US government under Section 232 to see whether pharma imports pose a threat to national security.

September 26, 2025 / 11:17 IST
Story continues below Advertisement
Trump tariffs

Indian pharma exports, which are primarily low-cost generic or copycat medicines, may not be impacted by US President Donald Trump's latest announcement of 100 percent tariffs on “any branded or patented" drugs imported into the US from October 1.

While generic drugs are exempted, companies still face uncertainty over tariffs due to an  investigation order by the US government under Section 232 to see whether pharma imports pose a threat to national security.

Story continues below Advertisement

"The latest tariff announcement is for branded or patented drugs, and not applicable to generics," Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance (IPA), told Moneycontrol.

IPA represents large homegrown pharmaceutical companies that have a significant exposure to the US market.